Development and Validation of a Treatment Benefit Index to Identify Hospitalized Patients With COVID-19 Who May Benefit From Convalescent Plasma

Hyung Park(New York University), Eva Petkova(Medical University Pleven), Dipyaman Ganguly(Indian Institute of Chemical Biology), Mengling Liu(Yichang Central People's Hospital), Elliott M. Antman(Brigham and Women's Hospital), Leandro Burgos Pratx(Hospital Italiano de Buenos Aires), Katharine J. Bar(California University of Pennsylvania), Yogiraj Ray, Ventura Simonovich(Hospital Italiano de Buenos Aires), Artur Belov(Center for Biologics Evaluation and Research), Paula Scibona(Hospital Italiano de Buenos Aires), Priscilla Y. Hsue(University of California, Los Angeles), C. Avendaño(Hospital Universitario Puerta de Hierro Majadahonda), Geert Meyfroidt(KU Leuven), André Moraes Nicola(Universidade de Brasília), Hyunah Yoon(Albert Einstein College of Medicine), Keith Goldfeld(New York University), Carlos H. Villa(Center for Biologics Evaluation and Research), Danni Wu(Zhejiang Provincial People's Hospital), Liise-anne Pirofski(Montefiore Medical Center), Bart Rijnders(Erasmus MC), Waldo Belloso(Hospital Italiano de Buenos Aires), Yinxiang Wu(University of Washington), Yin Huang(Center for Biologics Evaluation and Research), Nicole Verdun(Center for Biologics Evaluation and Research), Rafael F. Duarte(Institut Català d'Oncologia), Anne F. Luetkemeyer(University of California, San Francisco), Richard A. Forshee(Center for Biologics Evaluation and Research), Mila B. Ortigoza(New York University), Prasun Bhattacharya(Medical College and Hospital, Kolkata), Thaddeus Tarpey(New York University), Jinchun Zhang(Merck & Co., Inc., Rahway, NJ, USA (United States)), Yi Li(Nanyang Technological University), Aparna Mukherjee(Indian Council of Medical Research), Andrea B. Troxel(Andover Eye Associates), Anup Agarwal(Indian Council of Medical Research), Shekhar Ranjan Paul
JAMA Network Open
January 25, 2022
Cited by 66


Related Papers